RICHMOND, British Columbia, June 17, 2009 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) today announced that it has developed OncoPet(tm), a version of its RECAF(tm) blood test to be used for cancer detection in dogs.
RICHMOND, British Columbia, June 17, 2009 (GLOBE NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) today announced that it has developed OncoPet(tm), a version of its RECAF(tm) blood test to be used for cancer detection in dogs.
